Latest Share Purchase Plans News

Amplia Therapeutics has launched a $27.5 million capital raising to advance its lead drug Narmafotinib, a promising FAK inhibitor showing superior efficacy in pancreatic cancer trials. The funds will support ongoing and new clinical studies, positioning the company for pivotal regulatory milestones.

Amplia Therapeutics has successfully raised A$25 million through an institutional placement and launched a A$2.5 million Share Purchase Plan to fund pivotal clinical trials of its lead drug narmafotinib. The capital injection positions the company to advance key pancreatic and ovarian cancer studies into 2027.

QPM Energy has successfully raised $7 million through an oversubscribed Share Purchase Plan, significantly exceeding its initial $2 million target to accelerate key gas power projects in Queensland.

Australian Strategic Materials (ASM) reports significant progress in Q2 2025, including its first commercial heavy rare earth metals sale and a transformative low-cost production pathway at its Dubbo Project.

Miramar Resources has announced a $1 million Share Purchase Plan to fast-track drilling at its promising 8 Mile gold prospect near Kalgoorlie, following recent significant mineralisation discoveries.

Prescient Therapeutics has extended the closing date of its Share Purchase Plan to July 25, 2025, responding to shareholder demand and reinforcing strong participation. The oncology-focused biotech also highlights upcoming clinical milestones and ongoing investor engagement.

Strike Energy has announced a strategic placement and share purchase plan raising up to A$103 million to advance its core Perth Basin gas projects, backed by a significant investment from Carnarvon Energy. This funding underpins key developments targeting first production by late 2026 and a final investment decision for West Erregulla.

Carnarvon Energy is set to become Strike Energy’s largest shareholder through a strategic A$88 million equity placement, underpinning key project developments in Western Australia’s Perth Basin. Strike also launches a Share Purchase Plan to raise additional funds, aiming to accelerate production milestones by 2026.

Carnarvon Energy is set to invest up to A$88 million in Strike Energy through a two-tranche equity placement, positioning itself as Strike’s largest shareholder. This strategic move aims to accelerate development of Strike’s key Perth Basin assets, with production milestones targeted by 2026.

Riedel Resources has exceeded its initial capital raising target through its Share Purchase Plan, prompting an increase in the offer size to $400,000. This follows a recent $1 million placement, underscoring robust shareholder support as the company advances its Kingman Gold Project.

Microba Life Sciences reports record Q4 FY25 microbiome test sales in Australia and the UK, underpinned by landmark clinical studies and a $14.5 million capital raise. The company is transitioning away from legacy products to focus on high-value diagnostics, positioning for sustained growth in FY26.

Sunrise Energy Metals reports strong high-grade scandium drill results at Syerston and secures $7.5 million to accelerate project development. The company is updating its feasibility study amid growing market demand and geopolitical supply pressures.